Compare SCI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCI | RGEN |
|---|---|---|
| Founded | 1962 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.0B |
| IPO Year | 1994 | 1995 |
| Metric | SCI | RGEN |
|---|---|---|
| Price | $71.88 | $171.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 20 |
| Target Price | $92.29 | ★ $203.21 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 10-28-2026 | 10-27-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | 7.65 | ★ 286.96 |
| EPS | ★ 2.90 | N/A |
| Revenue | ★ $4,309,234,000.00 | $141,236,000.00 |
| Revenue This Year | $3.44 | $14.98 |
| Revenue Next Year | $3.67 | $26.05 |
| P/E Ratio | $25.33 | ★ N/A |
| Revenue Growth | 2.93 | ★ 35.10 |
| 52 Week Low | $68.41 | $100.99 |
| 52 Week High | $90.99 | $198.87 |
| Indicator | SCI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 47.16 |
| Support Level | $72.16 | $161.15 |
| Resistance Level | $84.99 | $188.59 |
| Average True Range (ATR) | 2.20 | 7.31 |
| MACD | -0.32 | -1.15 |
| Stochastic Oscillator | 6.60 | 34.91 |
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, it provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. The company derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.